OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume
Kenji Imai, Koji Takai, Satoshi Watanabe, et al.
Nutrients (2017) Vol. 9, Iss. 10, pp. 1054-1054
Open Access | Times Cited: 53
Kenji Imai, Koji Takai, Satoshi Watanabe, et al.
Nutrients (2017) Vol. 9, Iss. 10, pp. 1054-1054
Open Access | Times Cited: 53
Showing 1-25 of 53 citing articles:
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Mohammed Eslam, Shiv Kumar Sarin, Vincent Wai‐Sun Wong, et al.
Hepatology International (2020) Vol. 14, Iss. 6, pp. 889-919
Open Access | Times Cited: 648
Mohammed Eslam, Shiv Kumar Sarin, Vincent Wai‐Sun Wong, et al.
Hepatology International (2020) Vol. 14, Iss. 6, pp. 889-919
Open Access | Times Cited: 648
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
Mohammed Eslam, Jian‐Gao Fan, Ming‐Lung Yu, et al.
Hepatology International (2025)
Closed Access | Times Cited: 5
Mohammed Eslam, Jian‐Gao Fan, Ming‐Lung Yu, et al.
Hepatology International (2025)
Closed Access | Times Cited: 5
Sarcopenia and chronic liver diseases
Ching‐Sheng Hsu, Jia‐Horng Kao
Expert Review of Gastroenterology & Hepatology (2018) Vol. 12, Iss. 12, pp. 1229-1244
Closed Access | Times Cited: 86
Ching‐Sheng Hsu, Jia‐Horng Kao
Expert Review of Gastroenterology & Hepatology (2018) Vol. 12, Iss. 12, pp. 1229-1244
Closed Access | Times Cited: 86
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment
Anne‐Laure Couderc, Évelyne Liuu, Pascaline Boudou‐Rouquette, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1193-1193
Open Access | Times Cited: 28
Anne‐Laure Couderc, Évelyne Liuu, Pascaline Boudou‐Rouquette, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1193-1193
Open Access | Times Cited: 28
L‐Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis
Masatsugu Ohara, Koji Ogawa, Goki Suda, et al.
Hepatology Communications (2018) Vol. 2, Iss. 8, pp. 910-922
Open Access | Times Cited: 77
Masatsugu Ohara, Koji Ogawa, Goki Suda, et al.
Hepatology Communications (2018) Vol. 2, Iss. 8, pp. 910-922
Open Access | Times Cited: 77
Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index
Lukáš Müller, Felix Hähn, Aline Mähringer‐Kunz, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 5018-5018
Open Access | Times Cited: 44
Lukáš Müller, Felix Hähn, Aline Mähringer‐Kunz, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 5018-5018
Open Access | Times Cited: 44
Controlling Nutritional Status (CONUT) Predicts Survival in Gastric Cancer Patients With Immune Checkpoint Inhibitor (PD-1/PD-L1) Outcomes
Li Chen, Hao Sun, Ruihu Zhao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
Li Chen, Hao Sun, Ruihu Zhao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
The Egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Yasser Fouad, Gamal Esmat, Reda Elwakil, et al.
Saudi Journal of Gastroenterology (2022) Vol. 28, Iss. 1, pp. 3-20
Open Access | Times Cited: 33
Yasser Fouad, Gamal Esmat, Reda Elwakil, et al.
Saudi Journal of Gastroenterology (2022) Vol. 28, Iss. 1, pp. 3-20
Open Access | Times Cited: 33
Skeletal muscle volume loss during transarterial chemoembolization predicts poor prognosis in patients with hepatocellular carcinoma
Masashi Fujita, Atsushi Takahashi, Manabu Hayashi, et al.
Hepatology Research (2019) Vol. 49, Iss. 7, pp. 778-786
Closed Access | Times Cited: 52
Masashi Fujita, Atsushi Takahashi, Manabu Hayashi, et al.
Hepatology Research (2019) Vol. 49, Iss. 7, pp. 778-786
Closed Access | Times Cited: 52
Nutrition and Liver Disease
Claudia Mandato, Antonella Di Nuzzi, Pietro Vajro
Nutrients (2017) Vol. 10, Iss. 1, pp. 9-9
Open Access | Times Cited: 49
Claudia Mandato, Antonella Di Nuzzi, Pietro Vajro
Nutrients (2017) Vol. 10, Iss. 1, pp. 9-9
Open Access | Times Cited: 49
Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib
Kenji Imai, Koji Takai, Takao Miwa, et al.
Cancers (2019) Vol. 11, Iss. 8, pp. 1206-1206
Open Access | Times Cited: 45
Kenji Imai, Koji Takai, Takao Miwa, et al.
Cancers (2019) Vol. 11, Iss. 8, pp. 1206-1206
Open Access | Times Cited: 45
Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis
Christine March, Jazan Omari, Maximilian Thormann, et al.
Clinical Nutrition ESPEN (2022) Vol. 49, pp. 103-113
Closed Access | Times Cited: 24
Christine March, Jazan Omari, Maximilian Thormann, et al.
Clinical Nutrition ESPEN (2022) Vol. 49, pp. 103-113
Closed Access | Times Cited: 24
Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular Carcinoma
Hiroaki Matsumoto, Kaoru Tsuchiya, Hiroyuki Nakanishi, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3551-3551
Open Access | Times Cited: 23
Hiroaki Matsumoto, Kaoru Tsuchiya, Hiroyuki Nakanishi, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3551-3551
Open Access | Times Cited: 23
Prognostic significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib
Dong Dong, Jinyu Shi, Xiao Shang, et al.
Medicine (2022) Vol. 101, Iss. 5, pp. e28680-e28680
Open Access | Times Cited: 19
Dong Dong, Jinyu Shi, Xiao Shang, et al.
Medicine (2022) Vol. 101, Iss. 5, pp. e28680-e28680
Open Access | Times Cited: 19
Gender Different Impacts of Muscle Mass and Adipose Tissue on Patients With Hepatocellular Carcinoma Undergoing Surgical Resection
Pei‐Chang Lee, Tsung‐Yi Cheng, Chun‐Ting Ho, et al.
Liver International (2025) Vol. 45, Iss. 2
Closed Access
Pei‐Chang Lee, Tsung‐Yi Cheng, Chun‐Ting Ho, et al.
Liver International (2025) Vol. 45, Iss. 2
Closed Access
MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinoma
Na Qiang, Junjie Ao, Masato Nakamura, et al.
Biochemical Pharmacology (2025), pp. 116829-116829
Closed Access
Na Qiang, Junjie Ao, Masato Nakamura, et al.
Biochemical Pharmacology (2025), pp. 116829-116829
Closed Access
Increment of Skeletal Muscle Mass Predicts Survival Benefit for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Combining Molecular Targeted Agents and Immune Checkpoint Inhibitors
Wen Chen, Hai‐Tao Yan, Jin-Xing Zhang, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 415-426
Open Access
Wen Chen, Hai‐Tao Yan, Jin-Xing Zhang, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 415-426
Open Access
The relationship between systemic therapies and low skeletal muscle mass in patients with intermediate and advanced hepatocellular carcinoma
Jingjing Chen, Xueying Huang, Qiaoxin Wei, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Jingjing Chen, Xueying Huang, Qiaoxin Wei, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Effect of loop diuretics on skeletal muscle depletion in patients with liver cirrhosis
Tatsunori Hanai, Makoto Shiraki, Takao Miwa, et al.
Hepatology Research (2018) Vol. 49, Iss. 1, pp. 82-95
Open Access | Times Cited: 37
Tatsunori Hanai, Makoto Shiraki, Takao Miwa, et al.
Hepatology Research (2018) Vol. 49, Iss. 1, pp. 82-95
Open Access | Times Cited: 37
Sarcopenia in a mice model of chronic liver disease: role of the ubiquitin–proteasome system and oxidative stress
Fabián Campos, Johanna Ábrigo, Francisco Aguirre, et al.
Pflügers Archiv - European Journal of Physiology (2018) Vol. 470, Iss. 10, pp. 1503-1519
Closed Access | Times Cited: 35
Fabián Campos, Johanna Ábrigo, Francisco Aguirre, et al.
Pflügers Archiv - European Journal of Physiology (2018) Vol. 470, Iss. 10, pp. 1503-1519
Closed Access | Times Cited: 35
Prognostic Impact of Sarcopenic Obesity after Neoadjuvant Chemotherapy Followed by Surgery in Elderly Patients with Esophageal Squamous Cell Carcinoma
Sachiyo Onishi, Masahiro Tajika, Tsutomu Tanaka, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2974-2974
Open Access | Times Cited: 32
Sachiyo Onishi, Masahiro Tajika, Tsutomu Tanaka, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2974-2974
Open Access | Times Cited: 32
Immunonutritive Scoring in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Prognostic Nutritional Index or Controlling Nutritional Status Score?
Lukáš Müller, Felix Hähn, Aline Mähringer‐Kunz, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 27
Lukáš Müller, Felix Hähn, Aline Mähringer‐Kunz, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 27
Prognostic impact of skeletal muscle assessed by computed tomography in patients with acute myeloid leukemia
Nobuhiko Nakamura, Soranobu Ninomiya, Takuro Matsumoto, et al.
Annals of Hematology (2018) Vol. 98, Iss. 2, pp. 351-359
Closed Access | Times Cited: 30
Nobuhiko Nakamura, Soranobu Ninomiya, Takuro Matsumoto, et al.
Annals of Hematology (2018) Vol. 98, Iss. 2, pp. 351-359
Closed Access | Times Cited: 30
High subcutaneous adipose tissue density correlates negatively with survival in patients with hepatocellular carcinoma
Leona von Hessen, Marie Roumet, Martin Maurer, et al.
Liver International (2020) Vol. 41, Iss. 4, pp. 828-836
Open Access | Times Cited: 27
Leona von Hessen, Marie Roumet, Martin Maurer, et al.
Liver International (2020) Vol. 41, Iss. 4, pp. 828-836
Open Access | Times Cited: 27
Baseline Sarcopenia is Associated with Lack of Response to Therapy, Liver Decompensation and High Mortality in Hepatocellular Carcinoma Patients
Hanaa Badran, Maha Elsabaawy, Amr Ragab, et al.
Asian Pacific Journal of Cancer Prevention (2020) Vol. 21, Iss. 11, pp. 3285-3290
Open Access | Times Cited: 26
Hanaa Badran, Maha Elsabaawy, Amr Ragab, et al.
Asian Pacific Journal of Cancer Prevention (2020) Vol. 21, Iss. 11, pp. 3285-3290
Open Access | Times Cited: 26
